drugset

drugset / Trial / NCT01283984

AZD2115 Single Ascending Dose Study

NCT01283984 ↗

Phase 1 Completed 96 enrolled AstraZeneca

RandomizedParallel-groupTriple-blindBasic science

Summary

AZD2115 Single Ascending Dose Study

Timeline

Start: 2011-01
Primary completion: 2011-08
Completion: 2011-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZD2115	Unknown	—	Inhaled

Indications